NCT05010200 2026-01-07
PGV-Prostate
Icahn School of Medicine at Mount Sinai
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT06343077 2024-04-02
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT02643303 2022-12-02
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Ludwig Institute for Cancer Research
Phase 1/2 Completed
NCT03262103 2022-09-10
Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT00694551 2019-10-04
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed